Keeping pace with the constantly evolving regulatory requirements for biotech and pharmaceutical products is always challenging. For all types of companies, access to innovative technology is a key driver of regulatory outsourcing. At the same time, companies need support and guidance on how to use the expertise and technology available through outsourcing. The level and breadth of interest in regulatory outsourcing were evident from a recent survey of biotechnology and pharmaceutical companies conducted by Citeline on behalf of IQVIA.
Download this research paper to learn the technology needs and support of regulatory customers.
David Van Bruwaene was pursuing his Ph.D. in philosophy at Cornell when he developed a passion for linguistics and natural language processing, the subfiel
New nature-reporting recommendations aim to help companies assess their impact on and risks from the world’s natural systems. It could become mandatory one da
To the Editor:The article “Welcome to the ‘Walled Garden.’ Is This Education’s Solution to AI’s Pitfalls?” (July 25, 2023) raises important quest
A year and a half after Ukraine was invaded by Russia, 84% of the nation’s companies are fully operational, according to a survey by t
